chrX-49205209-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001256789.3(CACNA1F):c.5829C>T(p.Asp1943Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.006 in 1,209,072 control chromosomes in the GnomAD database, including 20 homozygotes. There are 2,280 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0039 ( 0 hom., 136 hem., cov: 22)
Exomes 𝑓: 0.0062 ( 20 hom. 2144 hem. )
Consequence
CACNA1F
NM_001256789.3 synonymous
NM_001256789.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.72
Genes affected
CACNA1F (HGNC:1393): (calcium voltage-gated channel subunit alpha1 F) This gene encodes a multipass transmembrane protein that functions as an alpha-1 subunit of the voltage-dependent calcium channel, which mediates the influx of calcium ions into the cell. The encoded protein forms a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Mutations in this gene can cause X-linked eye disorders, including congenital stationary night blindness type 2A, cone-rod dystropy, and Aland Island eye disease. Alternatively spliced transcript variants encoding multiple isoforms have been observed. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant X-49205209-G-A is Benign according to our data. Variant chrX-49205209-G-A is described in ClinVar as [Benign]. Clinvar id is 282023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.72 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00394 (441/111791) while in subpopulation NFE AF= 0.0055 (292/53093). AF 95% confidence interval is 0.00498. There are 0 homozygotes in gnomad4. There are 136 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 136 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1F | NM_001256789.3 | c.5829C>T | p.Asp1943Asp | synonymous_variant | 48/48 | ENST00000323022.10 | NP_001243718.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1F | ENST00000323022.10 | c.5829C>T | p.Asp1943Asp | synonymous_variant | 48/48 | 1 | NM_001256789.3 | ENSP00000321618.6 | ||
CACNA1F | ENST00000376265.2 | c.5862C>T | p.Asp1954Asp | synonymous_variant | 48/48 | 1 | ENSP00000365441.2 | |||
CACNA1F | ENST00000376251.5 | c.5667C>T | p.Asp1889Asp | synonymous_variant | 48/48 | 1 | ENSP00000365427.1 |
Frequencies
GnomAD3 genomes AF: 0.00395 AC: 441AN: 111740Hom.: 0 Cov.: 22 AF XY: 0.00401 AC XY: 136AN XY: 33896
GnomAD3 genomes
AF:
AC:
441
AN:
111740
Hom.:
Cov.:
22
AF XY:
AC XY:
136
AN XY:
33896
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00512 AC: 932AN: 181957Hom.: 0 AF XY: 0.00477 AC XY: 318AN XY: 66699
GnomAD3 exomes
AF:
AC:
932
AN:
181957
Hom.:
AF XY:
AC XY:
318
AN XY:
66699
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00620 AC: 6808AN: 1097281Hom.: 20 Cov.: 30 AF XY: 0.00591 AC XY: 2144AN XY: 362695
GnomAD4 exome
AF:
AC:
6808
AN:
1097281
Hom.:
Cov.:
30
AF XY:
AC XY:
2144
AN XY:
362695
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00394 AC: 441AN: 111791Hom.: 0 Cov.: 22 AF XY: 0.00401 AC XY: 136AN XY: 33957
GnomAD4 genome
AF:
AC:
441
AN:
111791
Hom.:
Cov.:
22
AF XY:
AC XY:
136
AN XY:
33957
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 07, 2015 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at